IP Verse

Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) - EP2756004

PATENT ANALYSIS

Patent Details

Grant Date
Dec 25, 2019
Company
REGENERON PHARMACEUTICALS, INC.
Oppositions

AMGEN INC.

BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBB

More patents of Regeneron Pharmaceuticals, Inc.

EP4011915

EP2967015

EP3384049

Want to monitor this patent?

Feel free to send us a message here and we will get back to you